Approaches to the Development of a Low-dose Naltrexone Preparation in the Form of a Nasal Spray (Review)

Introduction. Naltrexone hydrochloride belongs to µ-opioid receptor antagonists and is widely used in the treatment of alcohol and drug addiction at an oral dose of 50 mg/day. It is also a blocker of other receptors – opioid growth factor and Toll-like factor, which is especially evident at doses of...

Full description

Bibliographic Details
Main Authors: Yu. M. Domnina, V. V. Suslov, S. A. Kedik, P. O. Volkova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/852